Drug
14c Cr845
14c Cr845: highest development phase Phase 1, developed by Cara Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Cara Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C] CR845 NCT03947970 | Phase 1 | Hemodialysis |
Latest
No recent events.
Follow 14c Cr845 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.